Search Results - aloke+dutta

3 Results Sort By:
Novel Dual and Triple Acting CNS Compounds with Potential as Antidepressants, Medications for Attention Deficit Disorders and other Related Neuro-disorders
Wayne State University researchers have identified compounds with a unique molecular template exhibiting reuptake inhibition activity for both at the norepinephrine and serotonin transporters in the CNS. In addition, some of these molecules also exhibit triple reuptake activity for the dopamine, serotonin and norepinephrine transporters. These...
Published: 2/6/2014   |   Inventor(s): Aloke Dutta
Keywords(s): Antidepressants, Attention Deficit Disorders, Neuro-disorders, Neuroscience
Category(s): Therapeutics, Diseases, Life Science, Small molecule, Neurological disorders
Novel Hybrid Series of Compound Derived from 2-Aminotetralin and Piperazine Based Derivatives: Characterization for D1, D2, D3, D4 and other Serotonin Receptor Subtypes Binding
A series of compounds derived from 2-aminotetralin and piperazine fragments have been synthesized, which exhibit high CNS activity in vivo and in vitro. Some of the selected lead compounds have exhibited potent in vivo activity in a Parkinson’s disease animal model with long extended duration of action. In particular, these compounds show high...
Published: 2/6/2014   |   Inventor(s): Aloke Dutta, XianG-Shu Fei
Keywords(s):  
Category(s): Therapeutics, Diseases, Life Science, Small molecule, Neurological disorders
CNS Compounds Specific for the Monoamine Transporter Systems
The dopamine transporter (DAT) plays an important role in pathophysiological processes in the central nervous system. In cocaine addiction, binding of cocaine to the DAT and consequent blockage of dopamine uptake appears to be related to the reinforcing properties of the drug. Also associated with the transport function is concentration of neurotoxic...
Published: 3/31/2014   |   Inventor(s): Aloke Dutta
Keywords(s): Addiction Treatment, Antidepressants, Neuroscience, Parkinson's
Category(s): Therapeutics, Life Science